Assenagon Asset Management S.A. Buys 28,089 Shares of Henry Schein, Inc. $HSIC

Key Points

• Assenagon Asset Management S.A. increased its stake in Henry Schein, Inc. by 165.5%, owning 45,066 shares valued at approximately $3.29 million following the purchase of 28,089 shares in the second quarter.
• Henry Schein's stock performance shows a 1-year range of $60.56 to $82.49, with the company reporting a quarterly EPS of $1.10, missing estimates by $0.09.
• Institutional investors control 96.62% of Henry Schein's stock, with analysts currently rating the company as a "Hold" and having an average target price of $76.67.

Assenagon Asset Management S.A. grew its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 165.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,066 shares of the company's stock after purchasing an additional 28,089 shares during the period. Assenagon Asset Management S.A.'s holdings in Henry Schein were worth $3,292,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in HSIC. JPMorgan Chase & Co. increased its stake in Henry Schein by 6.5% during the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock valued at $436,489,000 after acquiring an additional 390,399 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Henry Schein by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock valued at $153,480,000 after purchasing an additional 103,384 shares during the period. Burgundy Asset Management Ltd. raised its stake in shares of Henry Schein by 33.9% in the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock valued at $153,105,000 after purchasing an additional 566,530 shares in the last quarter. Clarkston Capital Partners LLC raised its stake in shares of Henry Schein by 0.4% in the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company's stock valued at $119,965,000 after purchasing an additional 7,345 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Henry Schein by 1.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company's stock worth $82,440,000 after purchasing an additional 11,999 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

NASDAQ HSIC opened at $67.75 on Thursday. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a 50 day moving average of $68.64 and a 200-day moving average of $69.27. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.22 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 2.28 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the company earned $1.23 earnings per share. The firm's revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HSIC. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a report on Tuesday, August 26th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Sunday, September 7th. UBS Group cut their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Leerink Partners set a $75.00 price objective on Henry Schein in a research note on Monday, July 14th. Finally, Stifel Nicolaus restated a "hold" rating and set a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.